{
    "eid": "2-s2.0-85087817697",
    "title": "History of major bleeding predicts risk of clinical outcome of patients with atrial fibrillation: Results from the cool-af registry",
    "cover-date": "2020-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Geriatrics and Gerontology",
            "@code": "2717",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Anticoagulants",
        "Atrial fibrillation",
        "Major bleeding",
        "Outcomes"
    ],
    "authors": [
        "Rungroj Krittayaphong",
        "Arjbordin Winijkul",
        "Wattana Wongtheptien",
        "Chaiyasith Wongvipaporn",
        "Treechada Wisaratapong",
        "Rapeephon Kunjara-Na-Ayudhya",
        "Smonporn Boonyaratvej",
        "Pontawee Kaewcomdee",
        "Ahthit Yindeengam"
    ],
    "citedby-count": 2,
    "ref-count": 29,
    "ref-list": [
        "Stroke prevention in atrial fibrillation-an Asian stroke perspective",
        "The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe",
        "2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society",
        "2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS",
        "Prior bleeding, future bleeding and stroke risk with oral anticoagulation in atrial fibrillation: what new lessons can ARISTOTLE teach us?",
        "Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis",
        "Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation",
        "History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial",
        "A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey",
        "Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study",
        "Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a 'real world' nationwide cohort study",
        "Anticoagulation needs in asians with atrial fibrillation: a mythbuster",
        "Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients",
        "2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society",
        "Antithrombotic therapy for atrial fibrillation: CHEST Guideline and Expert Panel Report",
        "Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey",
        "Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF",
        "Stroke prevention in atrial fibrillation: an Asian perspective",
        "Sex-related differences in the clinical events of patients with atrial fibrillation-the Fushimi AF Registry",
        "Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation",
        "2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation",
        "Therapeutic strategies following major, clinically relevant nonmajor, and nuisance bleeding in atrial fibrillation: findings from ORBIT-AF",
        "Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy-pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry",
        "Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy",
        "2014 ACC/ AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons",
        "2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology",
        "2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)",
        "The prevalence and risks of inappropriate combination of aspirin and warfarin in clinical practice: results from WARFARIN-TR Study",
        "Rate of anticoagulant use, and factors associated with not prescribing anticoagulant in older Thai adults with non-valvular atrial fibrillation: a multicenter registry"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60011189",
            "affilname": "Faculty of Medicine Siriraj Hospital, Mahidol University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011189",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Khon Kaen",
            "@id": "60017165",
            "affilname": "Khon Kaen University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60017165",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60007641",
            "affilname": "Vichaiyut Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007641",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chiang Rai",
            "@id": "102066915",
            "affilname": "Chiangrai Prachanukroh Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/102066915",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Berlin Pharmaceutical Co.Ltd",
        "Department of Research, Faculty of Medicine Siriraj Hospital, Mahidol University",
        "Division of Clinical Epidemiology",
        "Health System Research Institute",
        "Heart Association of Thailand",
        "Health System Research Institute"
    ]
}